Pharmacologic treatments for covid-19 patients
Inhaled nebulised interferon beta-1a vs Placebo
This comparison will not be updated. Last search date 14 Dec, 2022
Hospitalized patients
Forest plots
(last update: 2021-06-18)
To access all information :
- click here for Hospitalized patients
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=163
Back to your research
Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
---|---|---|---|---|---|---|---|---|
Treatment 1 | Treatment 2 | |||||||
NCT04385095 ; EudraCT 2020-001023-14 Monk PD, Lancet Respir Med, 2020 Full text Commentary Commentary |
Private |
Nebulised interferon beta-1a |
Placebo |
RCT | Patients with confirmed COVID-19 (mild-severe) admitted to nine centers in the UK | N=101 |
Some concerns Details |